Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

aap Implantate AG issues Sales and EBITDA guidance for Q1 2014 and fiscal 2014 in line with analysts estimates

Thursday, 9 Jan 2014 11:25am EST 

aap Implantate AG:Announces that for 2014 the Management Board anticipates sales growth of approximately 10 percent to 44 million euros and an EBITDA between 6 million euros and 8 million euros, fiscal 2014 sales 44.52 million euros and EBITDA 8.11 million euros - Thomson Reuters I/B/E/S.Sees in the first quarter of 2014 it sales of between 8 million euros and 9 million euros and an EBITDA between 0.5 million euros and 1.5 million euros. 

Company Quote

-0.069 -2.82%
19 Dec 2014